The promotion of drugs in Indonesia is highly regulated, and the Food and Drugs Supervisory Agency or Badan Pengawas Obat dan Makanan (BPOM) has issued a new guideline on the advertising of drugs, i.e. Decision of the Head of BPOM No. 8 (2017) on Supervision Guidelines on the Advertising of Drugs.
BPOM Decision No.8 sets out the guidelines on the advertising of prescription drugs and non-prescription drugs.
Based on BPOM Decision No.8, prescription drugs may only be advertised in the medical scientific print media or scientific pharmaceutical print media. Only non-prescription drugs and limited non-prescription drugs can be advertised to the public through print media, electronic media and other media, subject to certain limitations allowed by the prevailing regulations.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
Business Law Digest is compiled with the assistance of Baker McKenzie. Readers should not act on this information without seeking professional legal advice. You can contact Baker McKenzie by emailing Danian Zhang at danian.zhang@bakermckenzie.com.
